REQUEST A DEMO
Total
USD $0.00
Search more companies

HMD BioMedical Inc. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: HMD BioMedical Inc. Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

HMD BioMedical Inc. is an enterprise located in Taiwan, China, with the main office in Hsinchu City. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on May 15, 2000. The total number of employees is currently 124 (2023). In Q2C2024, the company reported a net sales revenue drop of 10.85%. A growth of 7.19% was recorded in its total assets. The net profit margin of HMD BioMedical Inc. decreased by 7.67% in 2024.

Headquarters
No.181, Minsheng St. Xinpu Township
Hsinchu City; Hsinchu City;

Contact Details: Purchase the HMD BioMedical Inc. report to view the information.

Website: http://www.hmdbio.com

Basic Information
Total Employees:
Purchase the HMD BioMedical Inc. report to view the information.
Outstanding Shares:
Purchase the HMD BioMedical Inc. report to view the information.
Financial Auditors:
Purchase the HMD BioMedical Inc. report to view the information.
Incorporation Date:
May 15, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
7.17%
Purchase this report to view the information.
4.92%
Purchase this report to view the information.
3.68%
Purchase this report to view the information.
1.59%
Purchase this report to view the information.
Subsidiaries
1St Choice Co.,Ltd.
100%
Borvo Health, Inc. (United Kingdom)
85%
Company Performance
Financial values in the chart are available after HMD BioMedical Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-10.85%
Total operating revenue
-7.62%
Operating profit (EBIT)
-73.71%
EBITDA
-65.56%
Net Profit (Loss) for the Period
-67.78%
Total assets
7.19%
Total equity
3.13%
Operating Profit Margin (ROS)
-7.19%
Net Profit Margin
-7.67%
Return on Equity (ROE)
-4.7%
Debt to Equity Ratio
1%
Quick Ratio
-0.01%
Cash Ratio
0.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?